Latest filing published 09 Feb 2016 for Vaxart, Inc., €374.
Insider track record
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -21.1%Entry US$15.62 · Close at T+365 US$12.32
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Mark P. Colonnese: trading record in brief
Filings by Mark P. Colonnese span 2 companies, the busiest being Vaxart, Inc. and Atherogenics Inc. Between 20 March 2007 and 9 February 2016, the trades on record add up to 3 filings.
Every open-market trade on record is a purchase: 2 purchases worth €8,800, and no sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 1 option exercise. 2016 to date brings 2 purchases and no sales.
The latest filing, published on 9 February 2016, reports an open-market purchase of €374 in Vaxart, Inc. The median gap between trade and publication is zero days: most filings appear on the same day. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Mark P. Colonnese
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 300 shares@ US$1.39674.3% of flowCommon StockSEC:0001437749-16-025031:0Canonical exit: 9 May 2016 (T+90)
- 6,700 shares@ US$1.407195.7% of flowCommon StockSEC:0001437749-16-025031:1Canonical exit: 9 May 2016 (T+90)
- 25,000 shares@ US$0.38Common stockSEC:0001107601-07-000015:0
3 of 3 declarations
